U.S. Food and Drug Administration to Add Warning Label to Popular Flu Drugs
After 25 deaths in children while taking Tamiflu and an unusual number of occurrences of neurological disorders in children taking Relenza, a panel of pediatic experts will meet on November 27 to review the safety profile of the two most popular flu drugs. There is no evidence that directly links the drugs to the events but the unusual number of deaths and psychotic episodes including delirium and hallucinations has prompted the review.
[?]
Have a health issue you want to discuss or just a general issue regarding children? Register on Children's Health Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.
